106 related articles for article (PubMed ID: 7775937)
1. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas.
Lin JC; Lin SC; Luppi M; Torelli G; Mar EC
J Med Virol; 1995 Feb; 45(2):183-91. PubMed ID: 7775937
[TBL] [Abstract][Full Text] [Related]
2. Epstein--Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants.
Zhou XG; Sandvej K; Li PJ; Ji XL; Yan QH; Zhang XP; Da JP; Hamilton-Dutoit SJ
J Gen Virol; 2001 May; 82(Pt 5):1157-1167. PubMed ID: 11297690
[TBL] [Abstract][Full Text] [Related]
3. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
[TBL] [Abstract][Full Text] [Related]
5. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals].
Pavlish OA; Diduk SV; Smirnova KV; Shcherbak LN; Goncharova EV; Shalginskikh NA; Arkhipov VV; Kichigina MIu; Stepina VN; Belousova NV; Osmanov EA; Iakovleva LS; Gurtsevich VE
Vopr Virusol; 2008; 53(1):10-6. PubMed ID: 18318128
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of a 30-base pair deletion in the Epstein-Barr virus (EBV) latent membrane protein 1 gene and of strain type B EBV in Mexican classical Hodgkin's disease and reactive lymphoid tissue.
Dirnhofer S; Angeles-Angeles A; Ortiz-Hidalgo C; Reyes E; Gredler E; Krugmann J; Fend F; Quintanilla-Martinez L
Hum Pathol; 1999 Jul; 30(7):781-7. PubMed ID: 10414496
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
8. [Molecular characterization of Epstein-Barr virus associated with classical Hodgkin's lymphoma in Tunisia: prevalence of the LMP1 oncogene deletions and A and B viruses strains].
Trimeche M; Korbi S; Ziadi S; Amara K; Boniver J; de Leval L
Ann Biol Clin (Paris); 2005; 63(2):193-9. PubMed ID: 15771977
[TBL] [Abstract][Full Text] [Related]
9. [C-terminal 30 bp-deletion mutation of latent membrane protein 1 gene of Epstein-barr virus in non-hodgkin's lymphoma].
Liu JR; Lin Q; Wu XY
Ai Zheng; 2005 Feb; 24(2):145-8. PubMed ID: 15694022
[TBL] [Abstract][Full Text] [Related]
10. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
11. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
12. A strategy for precision of genotyping of Epstein-Barr virus by polymerase chain reaction: application for studying Hodgkin's lymphoma.
Lin JC; Lin SC; Mar EC
Leuk Lymphoma; 1994 Nov; 15(5-6):389-97. PubMed ID: 7873996
[TBL] [Abstract][Full Text] [Related]
13. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
Chabay P; De Matteo E; Merediz A; Preciado MV
Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma].
Han AJ; Zong YS; Zhang M; Cao SM; Lin SX; Liang YJ
Zhonghua Bing Li Xue Za Zhi; 2003 Dec; 32(6):534-8. PubMed ID: 14761599
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues.
Qi ZL; Han XQ; Hu J; Wang GH; Gao JW; Wang X; Liang DY
Mol Med Rep; 2013 Jan; 7(1):89-92. PubMed ID: 23128841
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
[TBL] [Abstract][Full Text] [Related]
17. Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease.
Vasef MA; Kamel OW; Chen YY; Medeiros LJ; Weiss LM
Am J Pathol; 1995 Nov; 147(5):1408-15. PubMed ID: 7485403
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
19. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
[TBL] [Abstract][Full Text] [Related]
20. Different distribution of H1-H2 Epstein-Barr virus variant in oropharyngeal virus and in biopsies of Hodgkin's disease and in nasopharyngeal carcinoma from Algeria.
Bouzid M; Sheng W; Buisson M; Bouguermouh A; Morand P; Seigneurin JM; Ooka T
Int J Cancer; 1998 Jul; 77(2):205-10. PubMed ID: 9650553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
